tiprankstipranks
Advertisement
Advertisement
Genprex Faces Nasdaq Delisting Notice, Plans Compliance Steps
PremiumCompany AnnouncementsGenprex Faces Nasdaq Delisting Notice, Plans Compliance Steps
1M ago
Genprex files $250M mixed securities shelf
Premium
The Fly
Genprex files $250M mixed securities shelf
2M ago
Genprex Highlights Biomarker Data for Reqorsa Lung Cancer Therapy
Premium
Company Announcements
Genprex Highlights Biomarker Data for Reqorsa Lung Cancer Therapy
2M ago
Genprex Highlights Promising Preclinical Data for Diabetes Gene Therapy
PremiumCompany AnnouncementsGenprex Highlights Promising Preclinical Data for Diabetes Gene Therapy
3M ago
Genprex Expands Lung Cancer Gene Therapy Research Collaboration
Premium
Company Announcements
Genprex Expands Lung Cancer Gene Therapy Research Collaboration
3M ago
Genprex enters research agreement with UT MD Anderson
Premium
The Fly
Genprex enters research agreement with UT MD Anderson
3M ago
Genprex granted Japanese and EU patents for Reqorsa Gene Therapy
PremiumThe FlyGenprex granted Japanese and EU patents for Reqorsa Gene Therapy
5M ago
Genprex Gains Australian Patent Acceptance for REQORSA Therapy
Premium
Company Announcements
Genprex Gains Australian Patent Acceptance for REQORSA Therapy
5M ago
Genprex’s patent application for Reqorsa Gene Therapy accepted by IP Australia
Premium
The Fly
Genprex’s patent application for Reqorsa Gene Therapy accepted by IP Australia
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100